Dezembro 2013 vol. 1 num. 2 - Brazilian Meeting on Organic Synthesis 2013
Abstract - Open Access.
Coumarins and Neoflavones: Synthesis and HCV NS5B Polymerase Inhibition
Moraes, Paula de F. de ; Leão, Raquel A. C. ; Nichols, Daniel Brian ; Basu, Amartya ; Chudayeu, Maksim ; Talele, Tanaji T. ; Kaushik-Basu, Neerja ; Costa, Paulo R. R. ;
Abstract:
Hepatitis C virus (HCV) is the leading cause of malignant chronic liver disease such as fibrosis, cirrhosis and hepatocellular carcinoma. Some years ago we report on the coumestan family of phytoestrogens as a new class of non-nucleoside HCV NS5B polymerase inhibitor. Wedelolactone and LQB-34 were the most potent (Figure 1). However, further efforts to optimize the coumestan scaffold proved discouraging as the synthesis of new derivatives involved multiple steps and expensive chemicals. We therefore sought to explore a trimmed version of coumestans, such as coumarins and neoflavones, which comprise of a bicyclic scaffold as opposed to a tetracyclic one present in LQB-34, as potential HCV NS5B inhibitors.
Abstract:
Palavras-chave: antiviral agents, coumarin, neoflavone,
Palavras-chave:
DOI: 10.5151/chempro-15bmos-BMOS2013_2013818222912
Referências bibliográficas
- [1] 1 Kaushik-Basu, N., e cols., Nucleic Acids Res. 2008, 36, 1482.
- [2] 2 Pocas E.S., e cols., Bioorg Med Chem. 2006, 14, 796
- [3] 3 Leão R. A. C., e cols., Synthesis-Stuttgart, 2011, 22, 3692.
- [4] 4 Nichols D. B., e cols., Chem. Biol. Drug Design, 2013, 81, 607.
Como citar:
Moraes, Paula de F. de; Leão, Raquel A. C.; Nichols, Daniel Brian; Basu, Amartya; Chudayeu, Maksim; Talele, Tanaji T.; Kaushik-Basu, Neerja; Costa, Paulo R. R.; "Coumarins and Neoflavones: Synthesis and HCV NS5B Polymerase Inhibition", p. 164 . In: In Blucher Chemistry Proceedings, São Paulo, v. 1, n. 2, Dezembro.2013.
São Paulo: Blucher,
2013.
ISSN 2318-4043,
DOI 10.5151/chempro-15bmos-BMOS2013_2013818222912
últimos 30 dias | último ano | desde a publicação
downloads
visualizações
indexações